References
- Wang J, Shen L, Lei L, Spinocerebellar ataxias in mainland China: an updated genetic analysis among a large cohort of familial and sporadic cases. Journal of Central South University Medical Sciences 2011;36:482–9.
- Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 2010;9: 885–94.
- Bettencourt C, Lima M. Machado-Joseph Disease: from first descriptions to new perspectives. Orphanet J Rare Dis 2011;6:35.
- Gaughwin PM, Ciesla M, Lahiri N, Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum Mol Genet 2011;20:2225–37.
- Hebert SS, Horre K, Nicolai L, MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 2009;33:422–8.
- Lee Y, Samaco RC, Gatchel JR, miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 2008;11:1137–9.
- Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009;136:642–55.
- Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215–33.
- Aumiller V, Forstemann K. Roles of microRNAs beyond development–metabolism and neural plasticity. Biochim Biophys Acta 2008;1779:692–6.
- Carissimi C, Fulci V, Macino G. MicroRNAs: novel regulators of immunity. Autoimmun Rev 2009;8:520–4.
- Aw S, Cohen SM. Time is of the essence: microRNAs and age-associated neurodegeneration. Cell Res 2012;22:1218–20.
- Huang Z, Huang D, Ni S, Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010;127:118–26.
- Cogswell JP, Ward J, Taylor IA, Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008;14:27–41.
- Gilad S, Meiri E, Yogev Y, Serum microRNAs are promising novel biomarkers. PloS One 2008;3:e3148.
- Sevcikova S, Kubiczkova L, Sedlarikova L, Serum miR-29a as a marker of multiple myeloma. Leuk Lymphoma 2013; 54:189–91.
- Schmidt MT, Handschuh L, Zyprych J, Impact of DNA microarray data transformation on gene expression analysis - comparison of two normalization methods. Acta Biochim Pol 2011;58:573–80.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–8.
- Pogue AI, Cui JG, Li YY, Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 2010;476:18–22.
- Roshan R, Ghosh T, Gadgil M, Pillai B. Regulation of BACE1 by miR-29a/b in a cellular model of Spinocerebellar ataxia 17. RNA Biol 2012;9:891–9.
- Shioya M, Obayashi S, Tabunoki H, Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 2010;36:320–30.
- Cheever A, Blackwell E, Ceman S. Fragile X protein family member FXR1P is regulated by microRNAs. RNA 2010;16:1530–9.
- Fang C, Zhu DX, Dong HJ, Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol 2012;91:553–9.
- Scholer N, Langer C, Dohner H, Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp Hematol 2010;38:1126–30.